
Mayne Pharma Group Ltd
ASX:MYX

Intrinsic Value
The intrinsic value of one
MYX
stock under the Base Case scenario is
hidden
AUD.
Compared to the current market price of 7.05 AUD,
Mayne Pharma Group Ltd
is
hidden
.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Mayne Pharma Group Ltd
Fundamental Analysis

A history of profit margin pressure in the generic drugs segment has undermined Mayne Pharma’s earnings stability, indicating that heightened competition could erode pricing power faster than the firm can offset with new product launches.
The specialty products focus, especially in dermatology and women’s health, holds potential for stronger margins, as these niches show sustainable demand and less direct competition than commodity generics.

Revenue & Expenses Breakdown
Mayne Pharma Group Ltd
Balance Sheet Decomposition
Mayne Pharma Group Ltd
Current Assets | 429.5m |
Cash & Short-Term Investments | 127.4m |
Receivables | 211.2m |
Other Current Assets | 90.9m |
Non-Current Assets | 701.2m |
PP&E | 57.5m |
Intangibles | 580.2m |
Other Non-Current Assets | 63.6m |
Free Cash Flow Analysis
Mayne Pharma Group Ltd
AUD | |
Free Cash Flow | AUD |
Earnings Waterfall
Mayne Pharma Group Ltd
Revenue
|
419.2m
AUD
|
Cost of Revenue
|
-169.7m
AUD
|
Gross Profit
|
249.5m
AUD
|
Operating Expenses
|
-368.7m
AUD
|
Operating Income
|
-119.2m
AUD
|
Other Expenses
|
-10.1m
AUD
|
Net Income
|
-129.2m
AUD
|
MYX Profitability Score
Profitability Due Diligence
Mayne Pharma Group Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Score
Mayne Pharma Group Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
MYX Solvency Score
Solvency Due Diligence
Mayne Pharma Group Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Score
Mayne Pharma Group Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MYX Price Targets Summary
Mayne Pharma Group Ltd
According to Wall Street analysts, the average 1-year price target for
MYX
is 7.55 AUD
with a low forecast of 7.47 AUD and a high forecast of 7.77 AUD.
Dividends
Current shareholder yield for MYX is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MYX
stock under the Base Case scenario is
hidden
AUD.
Compared to the current market price of 7.05 AUD,
Mayne Pharma Group Ltd
is
hidden
.